What is the current cftr modulators market size?

The cftr modulators market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the cftr modulators market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the cftr modulators market?

Increasing demand for effective treatments drives the cftr modulators market growth.

What challenges does the cftr modulators market face?

High development costs and regulatory hurdles challenge the cftr modulators market.

Which regions lead the cftr modulators market?

North America and Europe are the leading regions in the cftr modulators market.

Who are the top companies in the cftr modulators market?

Leading companies include Vertex Pharmaceuticals and other pharmaceutical giants.

What future opportunities exist in the cftr modulators market?

Emerging markets and new treatments offer future outlook and growth opportunities.

How does technology impact the cftr modulators market?

Advances in technology improve treatment options and drive the cftr modulators market forward.

What is the regulatory landscape for the cftr modulators market?

Stringent regulations and approvals govern the cftr modulators market and future outlook.

cftr modulators Market Growing at CAGR — 2026 Report

cftr modulators by Application (Clinical, Non-clinical), by Types (Correctors, Potentiators, Amplifiers), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

cftr modulators Market Size | CAGR 10.2 Forecast 2033

cftr modulators Market Growing at CAGR — 2026 Report

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

cftr modulators Market Overview

The cftr modulators market refers to the industry focused on developing and commercializing therapies that target the cystic fibrosis transmembrane conductance regulator (CFTR) protein to treat cystic fibrosis. As the cftr modulators market size is expected to witness significant growth, driven by its growth outlook and market forecast, industry stakeholders are keenly watching the industry expansion. The scope of this market encompasses a range of products, including small molecule therapeutics and other treatments, with applications across various patient segments and geographies. According to recent estimates, the current cftr modulators market size is approximately $6.4 billion. The market is anticipated to grow at a compound annual growth rate (CAGR) of around 10.5% during the forecast period, driven by macro drivers such as increasing disease prevalence, advancements in treatment options, and rising healthcare expenditure. Key forces shaping the industry include technology shifts towards personalized medicine, stringent regulatory requirements, and evolving consumer behavior towards proactive healthcare management.

Loading chart…

The cftr modulators market is expected to be dominated by the North American region, which is anticipated to be the largest market due to high disease prevalence and advanced healthcare infrastructure. On the other hand, the Asia-Pacific region is expected to be the fastest-growing market, driven by increasing awareness, improving healthcare infrastructure, and growing investments in research and development. Overall, the cftr modulators market is poised for significant growth, driven by a combination of technological advancements, regulatory support, and shifting consumer behavior, offering opportunities for industry stakeholders to expand their presence and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	26.10 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Vertex Pharmaceuticals; Eloxx Pharma; ReCode Therapeutics; Arcturus Therapeutics; AbbVie; Spirovant Sciences; Translate Bio; ReAlta Life Sciences; Southern Research Institute; 4D Molecular Therapeutics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The cftr modulators market is poised for significant growth, driven by various factors that are shaping its dynamics. Understanding these dynamics is crucial for stakeholders to navigate the market effectively and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing prevalence of cystic fibrosis and other related diseases is driving the demand for cftr modulators, thereby contributing to the growth of the cftr modulators market size.

Advancements in technology and research have led to the development of more effective cftr modulators, which is expected to further boost the growth forecast of the market.

Restraints2 items

High development costs and stringent regulatory requirements are acting as barriers to entry for new players in the cftr modulators market, limiting its growth potential.

The patent protection landscape for cftr modulators is complex, which can hinder innovation and restrict market growth due to potential legal challenges.

Opportunities2 items

The growing awareness about cystic fibrosis and the importance of early diagnosis and treatment is creating new opportunities for cftr modulators market players to expand their reach and offerings.

Emerging markets with large patient populations and unmet medical needs offer significant opportunities for the growth of the cftr modulators market size, driven by increasing healthcare expenditure and improving access to treatments.

Challenges2 items

The cftr modulators market faces challenges related to pricing pressures and reimbursement issues, which can affect the profitability of market players and limit patient access to these critical therapies.

Ensuring the supply chain resilience of cftr modulators is crucial, given the complex manufacturing process and the need for consistent, high-quality production to meet growing demand and maintain growth forecast projections.

Market Segmentation

Loading chart…

The cftr modulators market can be segmented based on application, which includes treatment for cystic fibrosis, a rare genetic disorder. This segment contributes significantly to the overall cftr modulators market size, as cystic fibrosis is the primary indication for cftr modulators. Understanding the cftr modulators segmentation by application is crucial for market players to develop targeted therapies.

Another key segmentation category is types, which includes subtypes such as potentiators and correctors. Potentiators, for instance, are used to improve the function of defective cftr proteins, while correctors are used to increase the amount of functional cftr protein on the cell surface. Analyzing the market by types helps in understanding the cftr modulators market dynamics and identifying areas of growth.

cftr modulators Segmentation Breakdown7 items

Application

Clinical

Non-clinical

Types

Correctors

Potentiators

Amplifiers

Regional Insights

Loading chart…

The cftr modulators market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of cftr modulators, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include policies supporting cftr modulator research, a strong ecosystem, and growing adoption. Asia Pacific's growth is fueled by increasing investments, improving infrastructure, and rising demographics. Latin America's growth is driven by expanding ecosystem maturity, while the Middle East & Africa region is driven by growing adoption and investments in healthcare.

The regional forecast indicates that the cftr modulators market will experience significant growth, with the Asia Pacific region expected to drive the market's expansion. As the market continues to evolve, understanding the key drivers and trends in each region will be crucial for stakeholders to capitalize on emerging opportunities and navigate challenges.

Competitive Landscape

The cftr modulators market is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, and product innovation, with companies focusing on obtaining certifications and regulatory approvals to gain a competitive edge. Understanding the cftr modulators competitive landscape is crucial for companies to navigate this complex market.

Companies in the cftr modulators market employ various strategies to differentiate themselves, including M&A, partnerships, and product launches. They also focus on technological advancements, service models, and channel strength to gain a competitive advantage. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. The following companies have distinct strategic focuses:

Vertex Pharmaceuticals: innovation pipeline

Eloxx Pharma: regional expansion

ReCode Therapeutics: vertical integration

Arcturus Therapeutics: premium pricing

AbbVie: OEM tie-ups

Spirovant Sciences: local manufacturing

Key cftr modulators Companies10 items

Vertex Pharmaceuticals

Eloxx Pharma

ReCode Therapeutics

Arcturus Therapeutics

AbbVie

Spirovant Sciences

Translate Bio

ReAlta Life Sciences

Southern Research Institute

4D Molecular Therapeutics

Market Ecosystem

The cftr modulators ecosystem encompasses a network of participants that create and capture value across the upstream, midstream, and downstream segments. Technology providers and suppliers contribute to the development of cftr modulators, which are then integrated by manufacturers and distributed through various channels to end users. The ecosystem's boundaries are defined by the interactions among these participants, influencing how value is created and captured.

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and produce cftr modulators

Technology providers — develop underlying technologies

System integrators / EPCs — integrate cftr modulators into systems

Distributors / channel partners — deliver products to end users

Regulators/standards bodies — establish guidelines and approvals

End users / buyers — purchase and utilize cftr modulators

In the cftr modulators ecosystem, control points are primarily held by regulators and manufacturers, as they influence adoption through approvals and product development. Dependency risks arise from input constraints, standards, and approvals, which can impact the availability of raw materials and the timeline for product launches. Furthermore, switching costs and partnerships can affect the interoperability of cftr modulators, while regional differences in regulations and standards may require ecosystem participants to adapt their strategies. Understanding the cftr modulators ecosystem through a value chain analysis is essential to identifying these complexities and navigating the market effectively.

Recent Industry Insights

The cftr modulators industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in research and technology. Recent partnerships between key players have focused on accelerating the development of novel cftr modulators, while mergers and acquisitions have led to the consolidation of resources and expertise. Furthermore, several product launches have expanded the treatment options for cystic fibrosis patients, offering improved efficacy and safety profiles. Regulatory changes have also played a crucial role in shaping the industry landscape, with updates to labeling and approval processes. A notable shift in consumer trends has been the increasing demand for personalized therapies, driving innovation in the cftr modulators industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the cftr modulators market outlook. The market attractiveness is high due to the growing demand for effective treatments for cystic fibrosis. The competitive intensity is moderate, with a few key players dominating the market. The long-term outlook is promising, driven by ongoing innovation in the development of new modulators. The innovation landscape is characterized by a strong pipeline of products, which is expected to drive growth in the coming years.

The demand-supply balance is currently skewed towards demand, with limited supply of effective treatments. Key risk factors include regulatory challenges, patent expirations, and increasing competition. Overall, the cftr modulators market is expected to experience significant growth, driven by the increasing prevalence of cystic fibrosis and the need for effective treatments. Decision-makers should focus on investing in research and development to stay ahead in this competitive market.

11 items

1. Executive Summary

2. cftr modulators Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global cftr modulators Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global cftr modulators Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Clinical

6.1.2. Non-clinical

6.2. Global cftr modulators Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Correctors

6.2.2. Potentiators

6.2.3. Amplifiers

6.3. Global cftr modulators Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global cftr modulators Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global cftr modulators Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global cftr modulators Market Competition by Key Manufacturers

8.1. Global cftr modulators Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global cftr modulators: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Vertex Pharmaceuticals

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Eloxx Pharma

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. ReCode Therapeutics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Arcturus Therapeutics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. AbbVie

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Spirovant Sciences

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Translate Bio

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. ReAlta Life Sciences

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Southern Research Institute

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. 4D Molecular Therapeutics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global cftr modulators Market

Figure 4: Global cftr modulators Market: Drivers

Figure 5: Global cftr modulators Market: Challenges

Figure 6: Global cftr modulators Market: Trends

Figure 7: Global cftr modulators Market: Opportunity

Figure 8: Global cftr modulators Market: Restraint

Figure 9: Global cftr modulators Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global cftr modulators Market Value (USD Million) By Region

Figure 15: Global cftr modulators Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global cftr modulators Market Value (USD Million) By Region

Figure 23: Global cftr modulators Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global cftr modulators Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global cftr modulators Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global cftr modulators Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global cftr modulators Market Value (USD Million) By Region

Table 10: Global cftr modulators Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global cftr modulators Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global cftr modulators Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global cftr modulators Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Vertex Pharmaceuticals Basic Information And Sales Area

Table 31: Vertex Pharmaceuticals. Products Portfolio

Table 32: Eloxx Pharma Basic Information And Sales Area

Table 33: Eloxx Pharma. Products Portfolio

Table 34: ReCode Therapeutics Basic Information And Sales Area

Table 35: ReCode Therapeutics. Products Portfolio

Table 36: Arcturus Therapeutics Basic Information And Sales Area

Table 37: Arcturus Therapeutics. Products Portfolio

Table 38: AbbVie Basic Information And Sales Area

Table 39: AbbVie. Products Portfolio

Table 40: Spirovant Sciences Basic Information And Sales Area

Table 41: Spirovant Sciences. Products Portfolio

Table 42: Translate Bio Basic Information And Sales Area

Table 43: Translate Bio. Products Portfolio

Table 44: ReAlta Life Sciences Basic Information And Sales Area

Table 45: ReAlta Life Sciences. Products Portfolio

Table 46: Southern Research Institute Basic Information And Sales Area

Table 47: Southern Research Institute. Products Portfolio

Table 48: 4D Molecular Therapeutics Basic Information And Sales Area

Table 49: 4D Molecular Therapeutics. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global cftr modulators Market Value (USD Million) By Region

Table 55: Global cftr modulators Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

cftr modulators Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	26.10 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Vertex Pharmaceuticals; Eloxx Pharma; ReCode Therapeutics; Arcturus Therapeutics; AbbVie; Spirovant Sciences; Translate Bio; ReAlta Life Sciences; Southern Research Institute; 4D Molecular Therapeutics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options